用hfCas13d介导的mRNA向治疗眼睛高血压的基因疗法
Siyu Chen1, Zhiquan Liu1, Chien-Hui Lo1
1Department of Ophthalmology, Stanford University School of Medicine, 1651 Page Mill Road, Rm 2220, Palo Alto, CA 94304, USA.
PNAS nexus
|June 27, 2025
概括
这项研究引入了使用CRISPR-Cas13来降低眼内压力 (IOP) 和保护视网膜质细胞 (RGCs) 的新型绿眼病基因疗法. 该疗法有效降低内血压,并在小鼠模型中促进RGC存活.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 玻璃眼会导致不可逆转的视力丧失,原因是眼内压力升高 (IOP) 和视网膜质细胞 (RGC) 损伤.
- 目前针对水性幽默动态的青光眼治疗方法往往不足以有效管理疾病.
研究的目的:
- 开发和评估使用RNA编辑来减少水性幽默产生的光瘤的向基因疗法.
- 评估击落水素1 (AQP1) 和碳酸酶2 (CA2) 基因在降低IOP和维护RGCs方面的有效性.
主要方法:
- 利用Cas13RNA编辑系统,准并击败参与水性幽默生成的AQP1和CA2基因.
- 在野生类型小鼠和皮质类固醇诱导的玻璃眼病小鼠模型中测试了hfCas13d介导的淘汰作用.
- 评估了IOP水平,水产生产,流出设施和RGC存活率.
主要成果:
- 在hfCas13d介导的AQP1和CA2中断,在野生类型和青光眼小鼠模型中显著降低了IOP.
- IOP的降低是由于水性幽默的产生减少,没有影响到外流设施.
- 与未经治疗的对照组相比,治疗显著促进了RGC存活率.
结论:
- 针对AQP1和CA2的CRISPR-Cas基因编辑为降低内血压提供了一个有希望的治疗策略.
- 这种方法证明了通过减少IOP和保持视力来治疗眼性视觉神经病变的潜力.
相关概念视频
01:28Angle Closure Glaucoma: Treatment
705
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
705
01:27Open Angle Glaucoma: Treatment
586
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
586
00:59Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K